Cancer News

Update on PARP Inhibitors for Ovarian Cancer with BRCA Mutations (10/31/2016)

Each year in the United States, roughly 22,000 women are diagnosed with ovarian cancer and more than 15,000 die of the disease. Treatment for ovarian cancer commonly involves surgery and/or chemotherapy. Researchers continue to study new approaches for improving the outcomes of all women affected by ovarian cancer but progress has been slow. The PARP … Continue reading "Update on PARP Inhibitors for Ovarian Cancer with BRCA Mutations"